Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) Operating margin 2021–2025
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) operating margin by fiscal year — reported operating income divided by reported revenue.
-11.3%FY2025 · since FY2021: -13.6% → -11.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.3% | +3.3 pp |
| FY2024 | -14.7% | -40.5 pp |
| FY2023 | 25.8% | +804.6 pp |
| FY2022 | -778.8% | -765.2 pp |
| FY2021 | -13.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice